Inventiva Announces Results From Phase IIb Clinical Trial with Lanifibranor in Systemic Sclerosis

    NEXT STORY
    Curetis’ Subsidiary Ares Genetics and QIAGEN Enter into Bioinformatics Partnership to Fight Antimicrobial Resistance
    PREV STORY
    Point of Care Testing Market Size Worth USD 38.40billion by 2026: Acumen Research And Consulting
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Tetraphase Pharmaceuticals Reports Fourth Quarter and Full-Year 2017 Financial Results, Highlights Achievements and Key 2018 Milestones

    Achieved positive results of Eravacycline in Phase 3 IGNITE 4 clinical trial for cIAI  ...

    author_avatar
    NASDAQ Market News

    Aduro Biotech to Present at Three Investor Conferences in the First Half of September

    BERKELEY, Calif., Aug. 31, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced ...

    author_avatar
    NASDAQ Market News

    Intensive Care Unit (ICU) Equipment Market to Reach USD 9.03 Billion by 2027; Surge in Cancer Patients to Amplify Business Deals, states Fortune Business Insights™

    author_avatar
    NASDAQ Market News